EVALUATION OF EARLY MARKERS OF CARDIOVASCULAR RISK IN SUBJECTS AFFECTED BY SYSTEMIC RHEUMATIC DISEASES

被引：0
|
作者：
Lanciano, E. [1 ]
Ciccone, M. M. [2 ]
Zito, A. P. [2 ]
Pinto, M. [2 ]
Gesualdo, M. [2 ]
Scicchitano, P. [2 ]
Sassara, M. [2 ]
Iannone, F. [1 ]
Lapadula, G. [1 ]
机构：
[1] Univ Bari, Sch Med, Rheumatol Unit, Bari, Italy
[2] Univ Bari, Cardiovasc Dis Sect, Bari, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.2712
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：400 / 400
页数：1
相关论文
共 50 条
  • [21] UNDERDIAGNOSIS OF TRADITIONAL CARDIOVASCULAR RISK FACTORS IN RHEUMATIC DISEASES
    Cecilia Reynosa-Silva, Ileana
    Angel Galarza-Delgado, Dionicio
    Jazmin Colunga-Pedraza, Iris
    Ramon Azpiri-Lopez, Jose
    de Jesus Hernandez-Galarza, Ivan
    Paola Cuellar-Calderon, Karla
    Castro-Gonzalez, Marielva
    Marlene Martinez-Flores, Carolina
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 637 - 638
  • [22] Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases
    Bartoloni, Elena
    Alunno, Alessia
    Gerli, Roberto
    NATURE REVIEWS CARDIOLOGY, 2018, 15 (01) : 33 - 44
  • [23] METHOTREXATE AND CARDIOVASCULAR RISK IN RHEUMATIC DISEASES:A COMPREHENSIVE REVIEW
    Verhoeven, F.
    Prati, C.
    Chouk, M.
    Demougeot, C.
    Wendling, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1159 - 1160
  • [24] RHEUMATIC DISEASES AND CARDIOVASCULAR RISK: IMPLICATIONS FOR CLINICAL PRACTICE
    Nurmohamed, M. T.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 29 - 29
  • [25] The cardiovascular risk of JAK inhibitors in treating rheumatic diseases
    Kwan, Alexander
    Ingrid, Elvina
    Jiang, Matthew
    Lim, Keith K. T.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (08)
  • [26] Update on Cardiovascular Disease Risk in Patients with Rheumatic Diseases
    Mackey, Rachel H.
    Kuller, Lewis H.
    Moreland, Larry W.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2018, 44 (03) : 475 - +
  • [27] Methotrexate and cardiovascular risk in rheumatic diseases:A comprehensive review
    Verhoeven, Frank
    Prati, Clement
    Chouk, Mickael
    Demougeot, Celine
    Wendling, Daniel
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (09) : 1105 - 1112
  • [28] Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases
    Elena Bartoloni
    Alessia Alunno
    Roberto Gerli
    Nature Reviews Cardiology, 2018, 15 : 33 - 44
  • [29] Novel Surrogate Markers of Cardiovascular Risk in the Setting of Autoimmune Rheumatic Diseases: Current Data and Implications for the Future
    Mandel, Anna
    Schwarting, Andreas
    Cavagna, Lorenzo
    Triantafyllias, Konstantinos
    FRONTIERS IN MEDICINE, 2022, 9
  • [30] Primer: the practical use of biological markers of rheumatic and systemic inflammatory diseases
    Eric Dayer
    Jean-Michel Dayer
    Pascale Roux-Lombard
    Nature Clinical Practice Rheumatology, 2007, 3 : 512 - 520
12345